Global Measles Vaccine Market Analysis 2016-2020 and Forecast 2021-2026

  • Report Code : 662471
  • Pages : 87
  • Published On : Mar 2021
  • Industry : Medical Devices
  • Format :

Choose License Type

Single User License: US$ 2,980
Multi User License: US$ 5,960
Corporate User License: US$ 5,960
Snapshot

The global Measles Vaccine market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Measles Vaccine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Children
Adults

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Measles Vaccine Industry
Figure Measles Vaccine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Measles Vaccine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Measles Vaccine
1.2.2 Downstream
Table Application Segment of Measles Vaccine
Table Global Measles Vaccine Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Measles Vaccine Market by Type
3.1 By Type
3.1.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
Table Major Company List of Mumps Measles Rubella Vaccine, Live (MMR-II)
3.1.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table Major Company List of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
3.2 Market Size
Table Global Measles Vaccine Market 2016-2020, by Type, in USD Million
Figure Global Measles Vaccine Market Growth 2016-2020, by Type, in USD Million
Table Global Measles Vaccine Market 2016-2020, by Type, in Volume
Figure Global Measles Vaccine Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Measles Vaccine Market Forecast 2021-2026, by Type, in USD Million
Table Global Measles Vaccine Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 GSK (Company Profile, Sales Data etc.)
4.1.1 GSK Profile
Table GSK Overview List
4.1.2 GSK Products & Services
4.1.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sanofi-Pasteur (Company Profile, Sales Data etc.)
4.2.1 Sanofi-Pasteur Profile
Table Sanofi-Pasteur Overview List
4.2.2 Sanofi-Pasteur Products & Services
4.2.3 Sanofi-Pasteur Business Operation Conditions
Table Business Operation of Sanofi-Pasteur (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Merck (Company Profile, Sales Data etc.)
4.3.1 Merck Profile
Table Merck Overview List
4.3.2 Merck Products & Services
4.3.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis (Company Profile, Sales Data etc.)
4.4.1 Novartis Profile
Table Novartis Overview List
4.4.2 Novartis Products & Services
4.4.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer (Company Profile, Sales Data etc.)
4.5.1 Pfizer Profile
Table Pfizer Overview List
4.5.2 Pfizer Products & Services
4.5.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Serum Institute of India (Company Profile, Sales Data etc.)
4.6.1 Serum Institute of India Profile
Table Serum Institute of India Overview List
4.6.2 Serum Institute of India Products & Services
4.6.3 Serum Institute of India Business Operation Conditions
Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 China National Biotech Group (Company Profile, Sales Data etc.)
4.7.1 China National Biotech Group Profile
Table China National Biotech Group Overview List
4.7.2 China National Biotech Group Products & Services
4.7.3 China National Biotech Group Business Operation Conditions
Table Business Operation of China National Biotech Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bavarian Nordic (Company Profile, Sales Data etc.)
4.8.1 Bavarian Nordic Profile
Table Bavarian Nordic Overview List
4.8.2 Bavarian Nordic Products & Services
4.8.3 Bavarian Nordic Business Operation Conditions
Table Business Operation of Bavarian Nordic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Emergent Biosolutions (Company Profile, Sales Data etc.)
4.9.1 Emergent Biosolutions Profile
Table Emergent Biosolutions Overview List
4.9.2 Emergent Biosolutions Products & Services
4.9.3 Emergent Biosolutions Business Operation Conditions
Table Business Operation of Emergent Biosolutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Medimmune (Company Profile, Sales Data etc.)
4.10.1 Medimmune Profile
Table Medimmune Overview List
4.10.2 Medimmune Products & Services
4.10.3 Medimmune Business Operation Conditions
Table Business Operation of Medimmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Johnson & Johnson (Company Profile, Sales Data etc.)
4.11.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.11.2 Johnson & Johnson Products & Services
4.11.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 CSL Limited (Company Profile, Sales Data etc.)
4.12.1 CSL Limited Profile
Table CSL Limited Overview List
4.12.2 CSL Limited Products & Services
4.12.3 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Measles Vaccine Sales Revenue 2016-2020, by Company, in USD Million
Table Global Measles Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Measles Vaccine Sales Revenue Share in 2020, by Company, in USD Million
Table Global Measles Vaccine Sales Volume 2016-2020, by Company, in Volume
Table Global Measles Vaccine Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Measles Vaccine Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Measles Vaccine Market Concentration, in 2020
Figure Europe Measles Vaccine Market Market Concentration, in 2020
Figure Asia-Pacific Measles Vaccine MMarket Concentration, in 2020
Figure South America Measles Vaccine Market Concentration, in 2020
Figure Middle East & Africa Measles Vaccine Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Children
Figure Measles Vaccine Demand in Children, 2016-2020, in USD Million
Figure Measles Vaccine Demand in Children, 2016-2020, in Volume
6.1.2 Demand in Adults
Figure Measles Vaccine Demand in Adults, 2016-2020, in USD Million
Figure Measles Vaccine Demand in Adults, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Measles Vaccine Demand Forecast 2021-2026, by Application, in USD Million
Figure Measles Vaccine Market Growth 2021-2026, by Application, in USD Million
Figure Measles Vaccine Market Share in 2026, by Application, in USD Million
Table Measles Vaccine Demand Forecast 2021-2026, by Application, in Volume
Table Measles Vaccine Market Growth 2021-2026, by Application, in Volume
Table Measles Vaccine Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Measles Vaccine Production 2016-2020, by Region, in USD Million
Table Measles Vaccine Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Measles Vaccine Market 2016-2020, by Region, in USD Million
Table Global Measles Vaccine Market Share 2016-2020, by Region, in USD Million
Table Global Measles Vaccine Market 2016-2020, by Region, in Volume
Table Global Measles Vaccine Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Measles Vaccine Market Size and Growth 2016-2020, in USD Million
Figure North America Measles Vaccine Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Measles Vaccine Market Size 2016-2020, by Country, in USD Million
Table North America Measles Vaccine Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Measles Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Europe Measles Vaccine Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Measles Vaccine Market Size 2016-2020, by Country, in USD Million
Table Europe Measles Vaccine Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Measles Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Measles Vaccine Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Measles Vaccine Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Measles Vaccine Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Measles Vaccine Market Size and Growth 2016-2020, in USD Million
Figure South America Measles Vaccine Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Measles Vaccine Market Size 2016-2020, by Country, in USD Million
Table South America Measles Vaccine Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Measles Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Measles Vaccine Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Measles Vaccine Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Measles Vaccine Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Measles Vaccine Market Forecast 2021-2026, by Region, in USD Million
Table Measles Vaccine Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion


List of Table
1. Table Upstream Segment of Measles Vaccine
2. Table Application Segment of Measles Vaccine
3. Table Global Measles Vaccine Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5. Table Global Measles Vaccine Market 2016-2020, by Type, in USD Million
6. Table Global Measles Vaccine Market 2016-2020, by Type, in Volume
7. Table Global Measles Vaccine Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Measles Vaccine Market Forecast 2021-2026, by Type, in Volume
9. Table GSK Overview List
10. Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table Sanofi-Pasteur Overview List
12. Table Business Operation of Sanofi-Pasteur (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Merck Overview List
14. Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Novartis Overview List
16. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Pfizer Overview List
18. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Serum Institute of India Overview List
20. Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table China National Biotech Group Overview List
22. Table Business Operation of China National Biotech Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Bavarian Nordic Overview List
24. Table Business Operation of Bavarian Nordic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Emergent Biosolutions Overview List
26. Table Business Operation of Emergent Biosolutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Medimmune Overview List
28. Table Business Operation of Medimmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Johnson & Johnson Overview List
30. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table CSL Limited Overview List
32. Table Business Operation of CSL Limited (Sales Revenue, Cost, Gross Margin)
33. Table Global Measles Vaccine Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Measles Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Measles Vaccine Sales Volume 2016-2020, by Company, in Volume
36. Table Global Measles Vaccine Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Measles Vaccine Demand Forecast 2021-2026, by Application, in USD Million
40. Table Measles Vaccine Demand Forecast 2021-2026, by Application, in Volume
41. Table Measles Vaccine Market Growth 2021-2026, by Application, in Volume
42. Table Measles Vaccine Market Share in 2026, by Application, in Volume
43. Table Measles Vaccine Production 2016-2020, by Region, in USD Million
44. Table Measles Vaccine Production 2016-2020, by Region, in Volume
45. Table Global Measles Vaccine Market 2016-2020, by Region, in USD Million
46. Table Global Measles Vaccine Market Share 2016-2020, by Region, in USD Million
47. Table Global Measles Vaccine Market 2016-2020, by Region, in Volume
48. Table Global Measles Vaccine Market Share 2016-2020, by Region, in Volume
49. Table North America Measles Vaccine Market Size 2016-2020, by Country, in USD Million
50. Table North America Measles Vaccine Market Size 2016-2020, by Country, in Volume
51. Table Europe Measles Vaccine Market Size 2016-2020, by Country, in USD Million
52. Table Europe Measles Vaccine Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Measles Vaccine Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Measles Vaccine Market Size 2016-2020, by Country, in Volume
55. Table South America Measles Vaccine Market Size 2016-2020, by Country, in USD Million
56. Table South America Measles Vaccine Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Measles Vaccine Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Measles Vaccine Market Size 2016-2020, by Country, in Volume
59. Table Measles Vaccine Market Forecast 2021-2026, by Region, in USD Million
60. Table Measles Vaccine Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List

List of Figure
1. Figure Measles Vaccine Industry Chain Structure
2. Figure Global Measles Vaccine Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Measles Vaccine Market Growth 2016-2020, by Type, in Volume
4. Figure Global Measles Vaccine Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Measles Vaccine Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Measles Vaccine Market Concentration, in 2020
7. Figure Europe Measles Vaccine Market Market Concentration, in 2020
8. Figure Asia-Pacific Measles Vaccine MMarket Concentration, in 2020
9. Figure South America Measles Vaccine Market Concentration, in 2020
10. Figure Middle East & Africa Measles Vaccine Market Concentration, in 2020
11. Figure Measles Vaccine Demand in Children, 2016-2020, in USD Million
12. Figure Measles Vaccine Demand in Children, 2016-2020, in Volume
13. Figure Measles Vaccine Demand in Adults, 2016-2020, in USD Million
14. Figure Measles Vaccine Demand in Adults, 2016-2020, in Volume
15. Figure Measles Vaccine Market Growth 2021-2026, by Application, in USD Million
16. Figure Measles Vaccine Market Share in 2026, by Application, in USD Million
17. Figure North America Measles Vaccine Market Size and Growth 2016-2020, in USD Million
18. Figure North America Measles Vaccine Market Size and Growth 2016-2020, in Volume
19. Figure Europe Measles Vaccine Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Measles Vaccine Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Measles Vaccine Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Measles Vaccine Market Size and Growth 2016-2020, in Volume
23. Figure South America Measles Vaccine Market Size and Growth 2016-2020, in USD Million
24. Figure South America Measles Vaccine Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Measles Vaccine Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Measles Vaccine Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Vero Cell Rabies Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...